WEBULL
WebtradeDownload

Bittium Oyj (HLSE:BITTI) Launched Faros Pro, Is The Stock Fully Priced?

Simply Wall St · 23h ago

Why Bittium Oyj Stock Is Back On Investors’ Radar

Bittium Oyj (HLSE:BITTI) has drawn fresh attention after launching its Faros Pro ambulatory ECG device and EasyFlex electrode patch, expanding its medical technology offering outside the United States.

The new Faros Pro system is built for long term ECG recording while patients continue daily life, aiming to offer clearer heart rhythm data, longer monitoring periods and a more convenient setup for both patients and healthcare providers.

For context, Bittium Oyj’s share price has pulled back recently, with a 7 day share price return down 6.74% and a 30 day share price return down 9.54%. Even though the year to date share price return is 19.31% and the 1 year total shareholder return is 179.01%, this points to strong longer term momentum as the Faros Pro launch adds a fresh talking point around the stock.

Scan how Bittium Oyj compares with other fast moving medical and technology stocks by reviewing our hand picked 616 high quality undiscovered gems.

The stock has cooled after a strong 1 year run, and Bittium Oyj now trades close to an estimated intrinsic value and below analyst targets. Is the recent pullback leaving more upside ahead, or already pricing in the Faros Pro story?

Most Popular Narrative: 11% Undervalued

The most followed narrative values Bittium Oyj at €38.88 per share, compared with the last close of €34.60. That gap is built on a detailed view of future defence and medical earnings.

The surge in defense and security order intake, alongside multiple pilot deliveries and ongoing negotiations (notably with Spain's Indra Group and BAE in the UK), positions Bittium to benefit from the global upswing in defense spending and modernization cycles, supporting potential above-trend revenue growth over the coming years.

To value all of this in today's terms, we will use a discount rate of 7.47%, as per the Simply Wall St company report. Read the complete narrative..

Want to see what sits behind that fair value for Bittium Oyj? The narrative leans on faster top line growth, firm margins and a richer future earnings multiple. Curious which assumptions really move the needle in this model?

Result: Fair Value of €38.88 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Bittium Oyj still faces two clear pressure points. Any delay or cancellation of large defence contracts, or weaker R&D investment, could quickly challenge this upbeat narrative.

Find out about the key risks to this Bittium Oyj narrative.

Another View On Bittium Oyj’s Valuation

The analyst narrative leans on discounted future earnings to argue Bittium Oyj looks about 11% undervalued at €38.88 per share. Yet on a simple P/E basis the stock trades on 44.2x, well above both European software peers at 23.5x and a fair ratio of 31.8x. That premium raises the question of how much good news is already priced in.

See what the numbers say about this price in our valuation breakdown, starting with the See what the numbers say about this price — find out in our valuation breakdown..

HLSE:BITTI P/E Ratio as at Sep 2026
HLSE:BITTI P/E Ratio as at Sep 2026

Next Steps

Mixed signals around Bittium Oyj's valuation and contracts can feel confusing, so review the full data and weigh both the 2 key rewards and 1 important warning sign.

Looking For More Investment Ideas Beyond Bittium Oyj?

If you are serious about building a stronger portfolio, do not stop at Bittium Oyj. Use these focused stock lists to uncover your next opportunity.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.